Search Results - "Coltman, CA Jr"

Clinical Trials: A Congressional Focus of Need by Coltman, Jr, CA

“…Senator Specter, Honorable Members of the Committee, it is my high privilege to speak on behalf of a subject near and dear to my heart. I have been involved in…”
Get full text

Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level less than or equal to 4.0 ng per Milliliter by Thompson, I M, Pauler, D K, Goodman, P J, Tangen, C M, Lucia, MS, Parnes, H L, Minasian, L M, d, L G, Lippman, S M, Crawford, ED, Crowley, J J, Coltman, CA Jr

“…The optimal upper limit of the normal range for prostate-specific antigen (PSA) is unknown. We investigated the prevalence of prostate cancer among men in the…”
Get full text

Hydroxyethyl starch and prednisone as adjuncts to granulocyte collection by Bearden, 3rd, J D, Coltman, Jr, C A, Ratkin, G A

“…A total of 232 leukaphereses were performed with a continuous flow (CFC) of 89 donors related to recipients to obtain granulocytes for infected…”
Get more information

Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study by Cowan, J D, Neidhart, J, McClure, S, Coltman, Jr, C A, Gumbart, C, Martino, S, Hutchins, L F, Stephens, R L, Vaughan, C B, Osborne, C K

“…Four hundred eleven women with metastatic breast cancer were randomly assigned to receive either 60 mg/m2 doxorubicin (130 patients), 320 mg/m2 bisantrene (146…”
Get more information

Trimetroprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: Evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled department of Veterans Affairs cooperative study by Ward, T T, Thomas, R G, Fye, CL, Arbeit, R, Coltman, CA Jr, Craig, W, Dana, B W, Finegold, S M, Lentino, J

“…Despite widespread use of trimethoprim-sulfamethoxazole (TMP-SMZ) for prophylaxis in neutropenic patients, questions remain regarding its efficacy, toxicity,…”
Get full text

The Clinical Significance of the Morphological Subdivision of Diffuse “Histiocytic” Lymphoma: A Study of 162 Patients Treated by the Southwest Oncology Group by Nathwani, Bharat N., Dixon, Dennis O., Jones, Stephen E., Hartsock, Robert J., Rebuck, John W., Byrne, Gerald E., Sheehan, William W., Kim, Hun, Coltman, Charles A., Rappaport, Henry

“…We grouped 162 patients with advanced, diffuse histiocytic lymphoma (DHL) into various’ morphological subtypes to ascertain whether there were any significant…”
Get full text

The clinical significance of the morphological subdivision of diffuse "histiocytic" lymphoma: a study of 162 patients treated by the Southwest Oncology Group by Nathwani, BN, Dixon, DO, Jones, SE, Hartsock, RJ, Rebuck, JW, Byrne, GE Jr, Sheehan, WW, Kim, H, Coltman, CA Jr, Rappaport, H

“…We grouped 162 patients wtih advanced, diffuse histiocytic lymphoma (DHL) into various morphological subtypes to ascertain whether there were any significant…”
Get full text

Platinum analogs in recurrent and advanced head and neck cancer: a Southwest Oncology Group and Wayne State University Study by Al-Sarraf, M, Metch, B, Kish, J, Ensley, J, Rinehart, J J, Schuller, D E, Coltman, Jr, C A

“…Cisplatin combinations are active in patients with epidermoid cancer of the head and neck. Because of the incidence of dose-limiting toxicity and the need for…”
Get more information

Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study by Tilchen, E J, Fleming, T, Mills, G, Oishi, N, Bonnett, J D, Natale, R B, Harker, G, Coltman, Jr, C A

Get more information

Combined alkylators and multiple-site irradiation for extensive small cell lung cancer: a Southwest Oncology Group Study by Livingston, R B, Schulman, S, Mira, J G, Harker, G, Vogel, S, Coltman, Jr, C A, Rivkin, S E, Budd, G T, Grever, M R, Crowley, J P

“…The Southwest Oncology Group performed a study for patients with extensive small cell lung cancer in which two hypotheses were tested: that combined alkylating…”
Get more information

Phase II study of fludarabine phosphate in previously untreated patients with colorectal carcinoma: a Southwest Oncology Group Study by Harvey, W H, Fleming, T R, Von Hoff, D D, Katterhagen, J G, Coltman, Jr, C A

Get more information

Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study by Ryan, D H, Kopecky, K J, Head, D, Gumbart, C N, Grever, M R, Karanes, C, Weick, J K, Coltman, Jr, C A

“…The Southwest Oncology Group undertook a phase II study of teniposide (VM-26) and ifosfamide in refractory adult acute lymphocytic leukemia. The 49 evaluable…”
Get more information

Phase II study of fludarabine phosphate for the treatment of advanced non-small cell carcinoma of the lung: a Southwest Oncology Group Study by Weiss, G R, Crowley, J, Von Hoff, D D, Taylor, S A, Belt, R J, Coltman, Jr, C A, Hynes, H E, Costanzi, J J

Get more information

Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer by Myers, J W, Von Hoff, D D, Clark, G M, Coltman, Jr, C A

Get more information

Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study by Ahmann, F R, Meyskens, Jr, F L, Jones, S E, Bukowski, R M, Saiers, J H, Ryan, D H, Costanzi, J, Vaughn, C B, Coltman, Jr, C A

“…A phase II trial was conducted to determine the clinical activity of amsacrine (m-AMSA) in patients with heavily pretreated solid tumors, myeloma, and lymphoma…”
Get more information